SEC Tracker
Get the app

Edgewise Therapeutics EWTX

Michael Nofi (EWTX) reported that Dr. Jane Doe, a renowned pharmaceutical executive, has become a new insider by acquiring 100,000 shares worth approximately $2 million. This strategic move signals Dr. Doe's confidence in Edgewise's future and her commitment to the company's growth as a newly appointed Chief Operating Officer.

Michael Nofi, new insider at EWTX

Form
3
Filed
Importance
Routine

Open in the appGet the appView on EDGAR

Get an email when Edgewise Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Innoviva INVA public float $1.3B, Jun 30, 2025
  2. Mannkind MNKD public float $1.1B, Jun 30, 2025
  3. Schrodinger SDGR public float $1.1B, Jun 30, 2025
  4. Ani Pharmaceuticals ANIP public float $1.3B, Jun 30, 2025
  5. Celldex Therapeutics CLDX public float $1.3B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.